Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheng Yan

Showing results (691-700 of 716) with videos related to

Pageof 72
Sort By:
Cell Death Discovery|November 1, 2023
NTRK1 knockdown induces mouse cognitive impairment and hippocampal neuronal damage through mitophagy suppression via inactivating the AMPK/ULK1/FUNDC1 pathwayKai Yang, Jue Wu, Shang Li, et al.
Oncogene|August 17, 2024
Ac4C modification of lncRNA SIMALR promotes nasopharyngeal carcinoma progression through activating eEF1A2 to facilitate ITGB4/ITGA6 translationSha Gong, Han Qiao, Jing-Yun Wang, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|June 22, 2024
LncRNA DYNLRB2-AS1 promotes gemcitabine resistance of nasopharyngeal carcinoma by inhibiting the ubiquitination degradation of DHX9 proteinKai-Lin Chen, Sai-Wei Huang, Ji-Jin Yao, et al.
Japanese Journal of Clinical Oncology|August 12, 2025
Tasurgratinib (E7090) for cholangiocarcinoma with fibroblast growth factor receptor 2 fusions/rearrangements: a multicenter, open-label, Phase 2 studyLin Shen, Huaxin Duan, Takamichi Kuwahara, et al.
BMC Medicine|April 22, 2024
Efficacy and safety of tislelizumab plus lenvatinib as first-line treatment in patients with unresectable hepatocellular carcinoma: a multicenter, single-arm, phase 2 trialLi Xu, Jinzhang Chen, Chang Liu, et al.
Experimental Neurology|November 8, 2021
Neuronal Glypican4 promotes mossy fiber sprouting through the mTOR pathway after pilocarpine-induced status epilepticus in miceKai-Ge Ma, Hai-Bo Hu, Jin-Song Zhou, et al.
Nature Communications|June 21, 2024
PJA1-mediated suppression of pyroptosis as a driver of docetaxel resistance in nasopharyngeal carcinomaSheng-Yan Huang, Sha Gong, Yin Zhao, et al.
Journal of Natural Medicines|May 5, 2024
Regulatory effect of Yinchenhao decoction on bile acid metabolism to improve the inflammatory microenvironment of hepatocellular carcinoma in miceJian Shi, Lin Zhu, Bang-Yi Tang, et al.
Cell Death & Disease|February 6, 2024
Transcription factor ATMIN facilitates chemoresistance in nasopharyngeal carcinomaXue-Liang Fang, Qing-Jie Li, Jia-Yi Lin, et al.
Horticulture Research|December 8, 2025
Pangenomics and single-cell transcriptomics uncover the genetic basis of continuous bearing trait in grapevineYuting Liu, Yang Dong, Xinyue Fang, et al.
Pageof 72

Showing results (691-700 of 716) with videos related to

Sort By:
Pageof 72
Cell Death Discovery|November 1, 2023
NTRK1 knockdown induces mouse cognitive impairment and hippocampal neuronal damage through mitophagy suppression via inactivating the AMPK/ULK1/FUNDC1 pathwayKai Yang, Jue Wu, Shang Li, et al.
Oncogene|August 17, 2024
Ac4C modification of lncRNA SIMALR promotes nasopharyngeal carcinoma progression through activating eEF1A2 to facilitate ITGB4/ITGA6 translationSha Gong, Han Qiao, Jing-Yun Wang, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|June 22, 2024
LncRNA DYNLRB2-AS1 promotes gemcitabine resistance of nasopharyngeal carcinoma by inhibiting the ubiquitination degradation of DHX9 proteinKai-Lin Chen, Sai-Wei Huang, Ji-Jin Yao, et al.
Japanese Journal of Clinical Oncology|August 12, 2025
Tasurgratinib (E7090) for cholangiocarcinoma with fibroblast growth factor receptor 2 fusions/rearrangements: a multicenter, open-label, Phase 2 studyLin Shen, Huaxin Duan, Takamichi Kuwahara, et al.
BMC Medicine|April 22, 2024
Efficacy and safety of tislelizumab plus lenvatinib as first-line treatment in patients with unresectable hepatocellular carcinoma: a multicenter, single-arm, phase 2 trialLi Xu, Jinzhang Chen, Chang Liu, et al.
Experimental Neurology|November 8, 2021
Neuronal Glypican4 promotes mossy fiber sprouting through the mTOR pathway after pilocarpine-induced status epilepticus in miceKai-Ge Ma, Hai-Bo Hu, Jin-Song Zhou, et al.
Nature Communications|June 21, 2024
PJA1-mediated suppression of pyroptosis as a driver of docetaxel resistance in nasopharyngeal carcinomaSheng-Yan Huang, Sha Gong, Yin Zhao, et al.
Journal of Natural Medicines|May 5, 2024
Regulatory effect of Yinchenhao decoction on bile acid metabolism to improve the inflammatory microenvironment of hepatocellular carcinoma in miceJian Shi, Lin Zhu, Bang-Yi Tang, et al.
Cell Death & Disease|February 6, 2024
Transcription factor ATMIN facilitates chemoresistance in nasopharyngeal carcinomaXue-Liang Fang, Qing-Jie Li, Jia-Yi Lin, et al.
Horticulture Research|December 8, 2025
Pangenomics and single-cell transcriptomics uncover the genetic basis of continuous bearing trait in grapevineYuting Liu, Yang Dong, Xinyue Fang, et al.
Pageof 72